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Introduction
Hyperimmunoglobulinemia D (HIDS) is the less severe
form of mevalonate kinase deficiency (MKD) caused by
recessive inherited mutation in the mevalonate kinase
gene (MVK). HIDS is characterized by febrile attacks,
often associated with transient digestive manifestations,
such as abdominal pain, diarrhea and vomiting.
Case report
Here we report for the first time two patients with MKD
revealed by a severe neonatal colitis. Both patients had
chronic bloody diarrhea and failure to thrive, one patient
since the age of one month and the other twelve days.
Total parenteral nutrition was required. A marked eleva-
tion of acute phase reactants was present, and no evidence
of infection was found. In patient 1, ileocolonoscopy
revealed an ulcerative colitis at the age of 5 months.
Patient 2 suffered from enterocolitis and shock, associated
with multiple bowel adhesions at age 5 weeks; the recto-
sigmoidoscopy showed aphtoid lesions of the sigmoid
colon. Pathological findings of colonic biopsies revealed a
dense polymorph inflammatory infiltrate associated with
deep ulcerations. Febrile attacks occurred 2 months after
the onset of digestive symptoms in patient 1, and at onset
of disease in patient 2. Genomic sequencing of the MVK
gene revealed compound heterozygous mutations in both
patients. Anti-interleukin 1 (Anti-IL1) agent (anakinra)
produced long-term remission of all digestive features and
laboratory parameters.
Discussion
This report emphasizes that MKD may be the cause of
severe early-onset inflammatory colitis, and must be con-
sidered by physicians, even in the absence of fever, after
ruling out infections. Anti-IL1 therapy may result in a
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